Financhill
Back

RAPT Therapeutics 10K Form

Sell
21

RAPT
RAPT Therapeutics

Last Price:
8.97
Seasonality Move:
35.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RAPT News And Ratings

See the #1 stock for the next 7 days that we like better than RAPT

RAPT Financial Statistics

Sales & Book Value

Annual Sales: $1.53M
Cash Flow: $-27.82M
Price / Cash Flow: 0
Annual Sales: $4.27
Price / Book: 2.11

Profitability

EPS (TTM): -3.05000
Net Income (TTM): $-116.8M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

RAPT Therapeutics Earnings Forecast

Key RAPT Therapeutics Financial Ratios

  • Per Share Earnings over the last 7 years have been positive in 1 years.

RAPT Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: RAPT
CUSIP: 75382E
Website: rapt.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RAPT Technical Analysis vs Fundamental Analysis

Sell
21
RAPT Therapeutics (RAPT) is a Sell

Is RAPT Therapeutics a Buy or a Sell?

  • RAPT Therapeutics stock is rated a Sell
    The current RAPT Therapeutics [RAPT] share price is $8.93. The Score for RAPT is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.